Simplifying Global Compliance
Pfizer, Endo Pay $50 Million to End Fraud Investigations
Pfizer and Endo will each pay $25 million to resolve claims the companies overcharged Texas’ Medicaid program for generic drugs.
To View This Article:
Subscribe To Generic Line
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing